The assay enables straightforward and rapid diagnosis during infancy and therefore allows early intervention such as nutritional management, physical therapy, or growth hormone treatment to prevent PWS patients from complications such as obesity and type 2 diabetes. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.